Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Condition(s):Neuromyelitis Optica Spectrum DisorderLast Updated:June 29, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Neuromyelitis Optica Spectrum DisorderLast Updated:June 29, 2023Not yet recruiting
Condition(s):Neuromyelitis Optica Spectrum DisordersLast Updated:October 5, 2023Not yet recruiting
Condition(s):Neuromyelitis Optica Spectrum DisorderLast Updated:August 14, 2023Recruiting
Condition(s):Neuromyelitis Optica Spectrum DisorderLast Updated:March 17, 2022Unknown status
Condition(s):Neuromyelitis Optica Spectrum DisorderLast Updated:September 22, 2022Not yet recruiting
Condition(s):Multiple Sclerosis; Neuromyelitis Optica Spectrum DisordersLast Updated:August 9, 2016Unknown status
Condition(s):Neuromyelitis Optica Spectrum DisordersLast Updated:January 18, 2024Not yet recruiting
Condition(s):Neuromyelitis Optica and Neuromyelitis Optica Spectrum DisordersLast Updated:December 3, 2021Completed
Condition(s):Neuromyelitis Optica Spectrum DisorderLast Updated:November 6, 2020Completed
Condition(s):Neuromyelitis Optica Spectrum DisordersLast Updated:February 21, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.